Rachel M. Werner (PARC Research Associate) and Alison M. Buttenheim (PSC Research Associate) were featured in an LDI Virtual Seminar, the first in the new "Experts at Home" series. The panel discusses the conundrums of COVID-19 including a timeline for treatment and vaccine, social distancing, and vulnerable children.
The proposal spearheaded by Alison M. Buttenheim,(PSC Research Associate) and Harsha Thirumurthy, (PSC/PARC Research Associate) have been named in the Top 100 in the MacArthur Foundation 100&Change competition, which offers a single $100 million grant to help solve one of the world’s most critical social challenges.
Alison M. Buttenheim (PSC Research Associate) and Harsha Thirumurthy (PSC/PARC Research Associate) have received a grant from the Bill and Melinda Gates Foundation to establish a first-of-its-kind nudge unit focused on HIV prevention in South Africa. They will co-lead this three-year initiative with their colleagues at HE²RO. Read more at Penn Nursing, Penn Medicine News and CHIBE’s blog.
Congratulations to Principal Investigators, Atul Gupta and David S. Mandell, alongside Co-Investigators, Alison M. Buttenheim, Norma Coe, and Harsha Thirumurthy, on receiving 2020 LDI pilot research grants. The various early stage health services research projects target challenges in health and health care delivery. Read more here
Alison Buttenheim, PhD, MBA , was invited by Representative Rosa DeLauro to brief the Congressional Baby Caucus on December 4, 2019, on the topic of vaccine hesitancy as a threat to infant health. Rep. DeLauro (D-CT) chairs the Caucus and holds regular briefings for interested members of Congress and their staff on topics relevant to child health and welfare. Read more here.
Harsha Thirumurthy, PhD, an associate director of Penn’s Center for Health Incentives & Behavioral Economics (CHIBE), and Alison Buttenheim, PhD, MBA, interim director of CHIBE, have received a three-year, $3.5 million grant from the Bill and Melinda Gates Foundation to establish a first-of-its-kind HIV-focused nudge unit in South Africa. The nudge unit will form partnerships with government and HIV services providers and test behavioral interventions to increase population-level coverage of HIV prevention services. The project will be led by CHIBE with a strong local partner, HE2RO (Health Economics and Epidemiology Research Office at Wits University in Johannesburg).
Alison Buttenheim was recently quoted in an article in the New York Times. Read "How Anti-Vaccine Sentiment Took Hold in the United States.
Alison Buttenheim is cited in a new article written by Isabel Fattal in The Atlantic about the complexities of policy change as it relates to school start times. Although people are not in agreement about what time high school should actually start, it is clear that many are slow to challenge the status quo. Buttenheim and a team of researchers wrote "Applying behavioral insights to delay school start times" published in Sleep Health. They suggest 4 strategies to influence decision-making processes and demonstrate how they can be applied to efforts aimed at changing school start time policies. Read the Atlantic article here.
A research study led by Alison Buttenheim of Penn Nursing focused on cases of pertussis (whooping cough) which have increased dramatically over the past five years, putting infants at risk of serious illness or death. The group valuated the feasibility and impact of different interventions aimed at increasing the number of vaccinated caregivers. The results of their study are available online here.
Newsworks.org reports Alison Buttenheim has found that many children who have vaccination exemptions have actually recieved at least one MMR vaccine, which increases the risks for the "truly unvaccinated".